Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.05
Bid: 5.00
Ask: 5.05
Change: 0.15 (3.06%)
Spread: 0.05 (1.00%)
Open: 4.965
High: 5.10
Low: 4.95
Prev. Close: 4.90
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CEO Long Term Incentive Plan

30 Sep 2019 07:00

RNS Number : 0253O
Seeing Machines Limited
30 September 2019
 

30 September 2019

Seeing Machines Limited

 

CEO Long Term Incentive Plan

 

Seeing Machines Limited (AIM: SEE) ("Seeing Machines" or the "Company"), the leading provider of AI-enabled driver monitoring technology for improved transport safety, advises that the Board has invited Paul McGlone, CEO, to participate in the Seeing Machines Employee Benefits Plan ("the Plan") and has awarded rights in respect of a total of 37,000,000 ordinary shares of no par value in the Company ("Ordinary Shares") as outlined below.

 

Pursuant to the terms of the Plan, rights in respect of a total of 25,000,000 Ordinary Shares have been awarded to Mr McGlone as part of the Company's Long Term Incentive Scheme. These Ordinary Shares will be issued at nil cost in five equal tranches commencing on 30 June 2020 and annually thereafter (the "Performance Date"), with each issue conditional on the satisfaction of key conditions including target share price performance prior to each Performance Date.

 

In addition, Mr McGlone has been awarded rights to acquire 12,000,000 Ordinary Shares as part of the Company's Call Option Scheme. These rights will vest on 1 July 2022 and will be exercisable at any point within one year at a price of 4.41 pence per Ordinary Share, being the average daily VWAP over the 5 trading days to 27 September 2019.

 

Seeing Machines encourages its key employees to participate in the success of the Company through the Plan giving them the opportunity to access long term incentives to ensure wealth is created for the benefit of all shareholders and other stakeholders.

 

Enquiries:

 

Seeing Machines Limited

+61 2 6103 4700

Paul McGlone - CEO

Sophie Nicoll - SVP, Corporate Communications

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Neil McDonald

Pete Lynch

+44 131 220 6939

 

 

Antenna Group for Seeing Machines (Media Enquiries)

 

SeeingMachines@antennagroup.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation

(EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to

be in the public domain.

 

Seeing Machines has also published its Director's Report on its website. See here: https://www.seeingmachines.com/investors/financial-reports/

 

About Seeing Machines - www.seeingmachines.com 

 

Seeing Machines (LSE: SEE), a global company headquartered in Australia, is an industry leader in computer vision technologies which enable machines to see, understand and assist people. The Company's machine learning vision platform has the know-how to deliver real-time identification and understanding of drivers through Artificial Intelligence (AI) analysis of heads, faces and eyes. This insight enables Driver Monitoring Systems (DMS), which monitor driver/operator identification and attention and can detect drowsiness and distraction across multiple transport sectors.

 

Seeing Machines develops DMS for the Automotive, Commercial Fleet, Aviation, Rail and Off-Road markets. The Company has offices in Australia, USA, Europe and Asia, and delivers multi-platform solutions to industry leaders in each vertical.

 

DMS is becoming a core safety technology integrated into ADAS offerings for the automotive industry, particularly with the development of semi-autonomous and self-driving cars. DMS is also increasingly seen to be an integral safety feature across the Commercial Transport & Logistics industry and is set to be become a regulatory requirement for all cars, vans, trucks and buses in Europe from 2022, with the rest of the world expected to follow soon after.

 

 

 

 

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Mr Paul McGlone

 

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Seeing Machines Limited

b)

LEI:

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

 

Identification code:

Performance Rights and Options Grant

 

ISIN: AU0000XINAJ0

b)

Nature of the transaction:

Issue of performance rights and share options

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

Nil - performance rights

25,000,000

4.41 pence - options

12,000,000

Total

37,000,000

 

d)

Aggregated information:

·; Aggregated volume:

·; Price:

See 4c) above and the schedules appended to this announcement

 

e)

Date of the transaction:

2019-09-25

f)

Place of the transaction:

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDMGZLKNKGLZM
Date   Source Headline
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.